About this trial
Laryngeal Mask Airways Are Supraglottic Devices Used to Maintain Airway Patency During Anesthesia and in Difficult Airways. LMA may help in reducing postoperative pulmonary complications. IV Dexmedetomidine Improves LMA Insertion Success and Decreases trials number, While IV Lidocaine Decreases Postoperative Cough. This is a randomized interventional trial comparing both drugs. IV DEX will be compared vs IV lidocaine regarding the feasibility of insertion, number of trials, incidence of cough, postoperative pulmonary complications and hemodynamic profile.
Eligibility criteria
Qualifiers
Parental/guardian consent.
Age 2-12 years
ASA physical status I-II.
Elective surgery requiring LMA (duration <2 hours).
Disqualifiers
Known airway anomalies (e.g., tonsillar hypertrophy, cleft palate).
Cardiovascular disease (bradycardia, arrhythmias).
Allergy to study drugs.
BMI >95th percentile.
Trial design
Treatments tested in this trial
- Dexamedomedine
- Lidocaine (drug)